TMPRSS2 and COVID-19: TMPRSS2 is a potential target for the treatment of COVID-19 due to its involvement in viral spike protein processing and localization in human epithelial tissues of the respiratory, genitourinary, and gastrointestinal tracts and its coexpression with the coronavirus receptor hACE2 in lung tissues.